Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v7-EN
Language English English
Date Updated 2022-05-24 2022-04-18
Drug Identification Number 02416794 02416794
Brand name JANUMET XR JANUMET XR
Common or Proper name sitagliptin and metformin hydrochloride modified-release tablets sitagliptin and metformin hydrochloride modified-release tablets
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients METFORMIN HYDROCHLORIDE SITAGLIPTIN METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 1000MG 50MG 1000MG 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2022-06-06 2022-05-09
Actual start date
Estimated end date 2022-06-13 2022-05-16
Actual end date 2022-05-24
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments